Condensed Consolidated Statements Of Earnings (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended
	Mar. 29, 2014	Mar. 30, 2013
Net sales	$ 1,363	$ 1,338
Cost of sales:
Cost of sales before special charges	382	359
Special charges	1	18
Total cost of sales	383	377
Gross profit	980	961
Selling, general and administrative expense	465	468
Research and development expense	170	160
Special charges	33	25
Operating profit	312	308
Other expense, net	20	48
Earnings before noncontrolling interest and income taxes	292	260
Income tax expense	53	38
Net earnings before noncontrolling interest	239	222
Net loss attributable to noncontrolling interest	(10)	(1)
Net earnings attributable to St. Jude Medical, Inc.	$ 249	$ 223
Net earnings per share attributable to St. Jude Medical, Inc.:
Basic	$ 0.88	$ 0.78
Diluted	$ 0.86	$ 0.78
Cash dividends declared per share:	$ 0.27	$ 0.25
Weighted average shares outstanding:
Basic	284.4	285.3
Diluted	289.3	287.4